"We were trying to understand how veterans were making decisions about germline testing for their prostate cancer," says Daniel Kwon, MD.

The decision comes after a pre-specified futility analysis determined that it was unlikely that the study would meet its primary end point.

"The scale of that linkage and the manner with which we were able to do it is really exciting and opens the door for a lot of future discovery," says Michael S. Leapman, MD, MHS.

The phase 1/2a SECuRE trial is evaluating the safety and efficacy of 67Cu-SAR-bisPSMA in the treatment of patients with mCRPC.

The phase 3 ENVISION trial met its primary end point by demonstrating a 79.6% complete response rate at 3 months following the first instillation of the therapy.

The AUSCO study assessed the artificial urinary sphincter's impact on incontinence and quality of life in men post-prostate surgery or with other urinary issues. Conducted across 18 sites, the study ...

"Generative AI technologies may play a valuable role in providing prompt, accurate responses to routine patient questions––potentially alleviating patients' concerns while freeing up clinic time and ...

PSMA-PET imaging enhances precision in radiation therapy for prostate cancer, improving treatment efficacy by accurately targeting cancerous areas. Emory study showed PET-guided radiation ...

The study involved a large international, multi-center cohort of approximately 4,000 patients undergoing inflatable penile prosthesis surgery. No significant differences in intraoperative or ...

Patient satisfaction is high due to the adaptive delivery of information and encouragement of feedback. Jenson incorporates common patient concerns into lectures, ensuring comprehensive information ...

Standardized guidelines for chaperone use are crucial to ensure consistency and enhance the patient-physician experience in genitourinary exams. Institutions vary in who can serve as a chaperone, with ...